Xolair 150 MG/ML syringeml
Ended Awarded
- Contract number
- SPE2DB25FY22Y
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $6,963
Award facts
- Contract value 100% obligated
- $6,963.30 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $6,963.30 by the Defense Logistics Agency (DLA) for Xolair 150 mg/ml syringes. The award, issued on September 3, 2025, with an ultimate completion date of September 24, 2025, is structured as a firm fixed-price delivery order with no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, a single-award vehicle valued at approximately $500 million and valid through November 2026, which enables the agency to procure a comprehensive range of pharmaceutical products to support Department of Defense healthcare facilities.
The SPE2DB contract represents a critical sourcing mechanism for the DLA to fulfill the pharmaceutical supply needs of military health systems worldwide. DMS Pharmaceutical Group has established itself as a key supplier within the federal pharmaceutical supply chain, with a demonstrated portfolio of delivery orders covering branded and generic prescription medications, biologics, and medical consumables. The Xolair delivery under this award supports the DLA's ongoing requirement to maintain inventory of immunological and specialty pharmaceutical products necessary for patient care across the DoD healthcare network.
Quick answers
Who was awarded contract SPE2DB25FY22Y?
SPE2DB25FY22Y was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 3, 2025.
How much is contract SPE2DB25FY22Y worth?
The government has obligated $6,963 on SPE2DB25FY22Y.
Is contract SPE2DB25FY22Y an order under another contract?
Yes. SPE2DB25FY22Y is a delivery order under SPE2DB22D9362, an indefinite delivery contract.
Was contract SPE2DB25FY22Y competed?
The extent of competition for SPE2DB25FY22Y was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award